CardioMEMS' Champion heart monitor fails to win over FDA advisory panel
This article was originally published in Clinica
CardioMEMS, a St Jude Medical-backed company, was dealt a blow by the FDA yesterday when the agency's advisory panel voted against the approval of the firm's Champion heart failure monitoring system.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.